- Report
- April 2025
- 200 Pages
Global
From €3966EUR$4,490USD£3,387GBP
- Report
- March 2025
- 200 Pages
Global
From €3966EUR$4,490USD£3,387GBP
- Report
- June 2025
- 361 Pages
Global
From €5167EUR$5,850USD£4,413GBP
- Report
- March 2024
- 200 Pages
Global
From €3665EUR$4,150USD£3,131GBP
OxyContin is a brand of extended-release oxycodone, an opioid analgesic used to treat moderate to severe pain. It is one of the most widely prescribed opioids in the United States and is used to treat chronic pain conditions such as cancer, arthritis, and lower back pain. OxyContin is a Schedule II controlled substance, meaning it has a high potential for abuse and addiction. It is typically prescribed in 12-hour doses, and is designed to provide a steady release of the drug over a longer period of time.
The analgesic market is highly competitive, with a variety of different drugs available to treat pain. OxyContin is one of the most popular opioids on the market, and is often prescribed as a first-line treatment for chronic pain. It is also used to treat acute pain, such as post-operative pain or pain associated with injury.
Companies in the OxyContin market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more